← FDA Drug Approvals (Drugs@FDA)

REVIA

NDA · New Drug Application · Sponsor: TEVA WOMENS · Approved 1984-11-20

Drug application

FDA Application #

NDA018932

Application type

New Drug Application

Brand name

REVIA

Generic name

Naltrexone Hydrochloride

Active ingredients

NALTREXONE HYDROCHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

TEVA WOMENS

First approval

1984-11-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown